NIH awarded The Alliance for Regenerative Rehabilitation Research and Training (AR3T) a 5-year renewal of the AR3T grant totaling $5,010,083. AR3T was one of six resource centers selected for this funding, all of which are a part of the Medical Rehabilitation Research Resource (MR3) Network.
Principal Investigators on this renewable effort are McGowan Institute for Regenerative Medicine affiliated faculty members:
- Fabrisia Ambrosio, PhD, MPT, Director of Rehabilitation for UPMC International and an Associate Professor in the Department of Physical Medicine & Rehabilitation at the University of Pittsburgh
- Michael Boninger, MD, Professor in the Department of Physical Medicine & Rehabilitation at the University of Pittsburgh School of Medicine, and Senior Medical Director for Post-Acute Care for the Health Services Division of UPMC and President of UPMC Innovative Homecare Solutions
- Thomas Rando, MD, PhD, Professor, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, and the Director, Glenn Laboratories for the Biology of Aging, and the Deputy Director, Stanford Center on Longevity
An alliance of nationally recognized researchers guides AR3T from the University of Pittsburgh, Stanford University, Mayo Clinic, and the University of Texas at Austin.
AR3T’s overarching goal is to support the expansion of scientific knowledge, expertise, and methodologies across the domains of rehabilitation science and regenerative medicine. In addition to providing research support, education opportunities, mentored collaborative opportunities, and funds for pilot projects and technology development projects, this new cycle will also focus on supporting workforce diversity.
Congratulations and best wishes for continued success!
Illustration: The Alliance for Regenerative Rehabilitation Research and Training (AR3T).